Melanotan II
Melanotan II is a synthetic cyclic research peptide supplied as a 10mg lyophilised preparation for controlled laboratory investigation.
It is studied in experimental models examining melanocortin receptor binding, receptor selectivity and peptide-mediated signalling pathways.
Area of Interest
Research into Melanotan II has highlighted several areas of scientific exploration:
Melanocortin Receptor Interaction:
Studied for its affinity with melanocortin receptors and the signalling pathways associated with these receptor systems.
Peptide Signalling Mechanisms:
Explored in laboratory models investigating how synthetic peptide analogues influence receptor activity and downstream biochemical processes.
Comparative Peptide Research:
Examined alongside naturally occurring melanocortin peptides to better understand structural modifications and receptor binding behaviour.
Receptor Pharmacology Studies:
Used in experimental models evaluating melanocortin receptor selectivity and peptide-mediated signalling responses.
These areas continue to make Melanotan II a compound of interest within ongoing peptide and receptor interaction research.
Research Classification
Product Name: Melanotan II 10mg
Molecular Weight: 1024.2 g/mol
Sequence: Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂
Purity: ≥99%
Form: Lyophilised Solid
Storage and Handling
Melanotan II is supplied as a lyophilised solid to maximise stability during storage and transportation. For optimal preservation, the product should be stored according to the reconstitution and storage guidelines provided on the Evolve Peptides website. Standard laboratory handling procedures should always be followed when working with peptide compounds.
Important Notice
This product is supplied strictly for laboratory research purposes only. It is not approved for human or veterinary use, and must not be used in food, drugs, cosmetics, or any consumable products. All information provided is intended solely for scientific and educational reference within controlled research environments.
